previous anti-tuberculosis treatment, human immunodeficiency virus infection, not receiving directly observed treatment, advanced chest radiography findings, multidrug-resistant TB (MDR-TB) and extra-pulmonary TB. For all-cause mortality, predictors were similar except for rural dwelling and nationality (higher mortality among locals). Absence of BCG scar, previous treatment for TB and MDR-TB were not found to be predictors of all-cause mortality. Indigenous populations in East Malaysia had lower rates of unfavourable treatment outcomes.
C O N C L U S I O N S :
One fifth of TB patients had unfavourable outcomes. Intervention strategies should target those at increased risk of unfavourable outcomes and allcause mortality. K E Y W O R D S : treatment outcome; risk factors; tuberculosis; indigenous populations MORE THAN 130 YEARS AGO, Robert Koch shared his discovery of Mycobacterium tuberculosis with the global scientific community. He presented statistics that showed tuberculosis (TB) was a greater killer than plague and cholera, with one in seven dying from the disease. 1 Even today, the disease continues to kill more than a million people annually, despite the availability of effective medication with high cure rates of 90% since the 1960s. 2 Left untreated, more than two thirds of patients die within 10 years. 2 Malaysia is located in the South-East Asia region. It is categorised as an upper middle-income country, with a population size of over 32 million individuals, of whom 7.8% are foreigners 3 and 12% are indigenous. The majority of the indigenous population resides in East Malaysia (Sabah and Sarawak). 4 The Western Pacific Region, of which Malaysia is part, accounted for nearly 60% of the world's TB cases in 2012. 2 Three of the 22 countries with the world's highest TB burden (Indonesia, the Philippines and Thailand) are neighbouring countries. 2 In 1961, Malaysia started a National TB Control Programme, and a TB registry was established in 1973. Data were initially collected manually; 5 an electronic information database was developed in 2010 and was fully implemented by 2012. The recording and reporting of TB cases informs health care providers and policy makers about the impact of TB. Surveillance is considered a vital component of the World Health Organization (WHO) Stop TB strategy, which in 1990 aimed to halve the number of TB cases by 2015. 6 Despite the institution of a surveillance programme, Malaysia's treatment success rate remains below 90%. 2 Studies looking at predictors of treatment outcomes have used varying definitions of outcomes, such as relapse, mortality, multidrugresistant TB (MDR-TB) status, and a combination of treatment failure, treatment interruption or death. [7] [8] [9] Risk factors for unfavourable outcomes have been reported to include socio-economic factors (age, sex employment and education), patient factors (such as diabetes status, smoking and body mass index), disease factors (history of multiple disease treatment, history of receiving directly observed treatment (DOT) and MDR-TB) and health care system factors (attending health centres in regional capitals, hospital referrals). [7] [8] [9] [10] [11] [12] [13] In the present study, we aimed to look at the 2012 cohort of patients registered in the Malaysian national TB registry to determine treatment outcomes and associated predictors.
MATERIALS AND METHODS
This was a retrospective cohort of all patients registered in the 2012 Malaysian National TB Surveillance Database. TB is a notifiable disease under Malaysian law. 14 Medical history, including sociodemographic characteristics, smoking history and comorbidities, were obtained by the attending doctor. All TB patients underwent a blood glucose test for diabetes mellitus (DM) and a rapid test for human immunodeficiency virus (HIV) infection. The data were then entered into the national TB registry by the health inspector of the respective District Health Office that received the notification report.
Treatment outcomes were recorded at 1-year follow-up using to the following WHO categories: cure, treatment completion, treatment default, treatment failure, death, transfer out of the country and loss to follow-up. 2, 5 Favourable outcomes were defined as cases that resulted in cure or treatment completion; all other outcomes (treatment failure, allcause mortality, transfer out and loss to follow-up, treatment default and outcome not evaluated) were defined as unfavourable outcomes.
Cure was defined as a negative sputum culture in the last month of treatment and on at least one previous occasion. Treatment completion was defined as completing treatment without meeting the criteria for cure or treatment failure. A patient who died before starting treatment or during the course of treatment was classified as a death, irrespective of cause. Treatment failure was defined as remaining sputum smear-positive or becoming sputum smearpositive again after treatment for 75 months. This category also included those who were sputumnegative at the start of treatment and later became sputum-positive after 2 months of treatment. Treatment default was defined as treatment interrupted for 72 consecutive months. Transfer out and loss to follow-up was defined as transfer to another country with unknown treatment outcome. Outcome not evaluated was defined as patients who were undergoing treatment and whose outcomes were not known.
New cases were those who had never been treated for TB or had taken anti-tuberculosis drugs for ,1 month. Previously treated patients were those who had received 71 month of anti-tuberculosis drugs in the past. MDR-TB was defined as resistance to both rifampicin and isoniazid. Relapse cases were those who had completed treatment and/or had been cured, but diagnosed again with active TB on the basis of sputum smear positivity or by clinical diagnosis based on bacteriological, histological or radiological examination.
Data were analysed using SPSS statistical software package, version 18.0 (Statistical Package for the Social Sciences, Armonk, NY, USA). Sociodemographic and clinical data were described using proportions. Univariate and multivariate binary logistic analyses were used, with unfavourable treatment and death as outcomes.
The names and identifiers of the patients in the database were anonymised and kept confidential. The study was approved by the Malaysia Ministry of Health Medical Research Ethics Committee, Putrajaya, Malaysia (reference number NMRR-13-1273-17586).
RESULTS
A total of 21 582 patients were registered in the Malaysian national tuberculosis surveillance database in 2012. Table 1 summarises the sociodemographic characteristics of these patients. The mean age was 42.36 6 17.77 years. About one in seven (14.2%) were non-Malaysians. Nearly a quarter (24.3%) of the local citizens with TB were of indigenous origin. Table 2 shows the disease profile and outcomes of the cohort. The majority were new cases (n ¼ 20 146, 93.6%) who presented with symptoms. Treatment outcomes were reported in 21 423, of whom 78.5% had favourable outcomes.
The Figure summarises the proportion of patient outcomes. One in five patients had an unfavourable outcome. Of these, nearly half died, while the other half transferred out or defaulted from treatment. Only 1% failed treatment. Of those who were transferred out (n ¼ 1100), 856 (77.8%) were foreign citizens. Of the patients with favourable outcomes, 62% were cured and 38% completed treatment. Table 3 shows the factors associated with unfavourable outcomes in patients with TB using univariate and multivariate analysis. Factors associated with unfavourable TB treatment outcomes were older age, male sex, foreign citizenship, lower education levels, absence of bacille Calmette-Guérin (BCG) scar, undergoing treatment at a public hospital, smoking, previous treatment for TB, HIV positivity, not receiving DOT, advanced chest radiography (CXR) findings, MDR-TB and extra-pulmonary TB (EPTB). Indigenous people in Malaysia were found to have a lower risk of unfavourable outcomes. DM, sputum smear negativity and residence in urban areas were not found to be predictors after adjustment for other factors. Table 4 shows the results from univariate and multivariate logistic analyses on factors associated with all-cause mortality in TB patients. Factors associated with death were older age, male sex, local citizenship, lower education levels, living in rural areas, undergoing treatment in a public hospital, HIV positivity, not receiving DOT, advanced CXR findings and EPTB. Indian ethnicity and indigenous East Malaysian populations were found to be at lower risk of death. Smoking was found to be a predictor for mortality in univariate analysis; however, this was reversed in the multivariate analyses, indicating that other predictors had stronger associations with death as an outcome. Other ethnicities, absence of BCG scar, diabetes, previous treatment for TB and sputum smear negativity were not found to be predictors of all-cause mortality after adjusting for other factors.
Further analyses of the indigenous population (Table 5) showed that the group in East Malaysia (Sabah and Sarawak) were similar in age to the nonindigenous population. The West Malaysian indigenous population were significantly younger than other populations. The rates of diabetes and HIV infection in both East and West Malaysia indigenous populations were lower than in the non-indigenous population. DOT rates were higher in the indigenous populations.
DISCUSSION
We found that 78.5% of TB patients in the 2012 Malaysian TB registry had favourable outcomes, one in five had an unfavourable outcome, and one in 10 patients died. There has thus been little progress in reducing mortality rates since Koch first described the disease more than a century ago, reporting a fatality rate of one in seven patients. 1 The rate of mortality in patients with smear-positive TB has been reported to be 21% in Japan, 10% in Micronesia, 14% in Hong Kong and 15% in Singapore. 2 Although TB is a treatable disease and considered a problem of the developing world, it remains a global threat. Possible reasons for the high rate of mortality include disease comorbidity and incomplete treatment leading to drug resistance. 12 We observed that half of those with poor treatment outcomes had defaulted from treatment (25%) or were transferred out and lost to follow-up (24%). The number of patients transferred out and lost to follow-up was high compared with other studies that reported few transfers out. 8, 9 Among those who transferred out, the majority were foreign citizens. In Malaysia, the health policy is to deport foreigners with active TB within a month. 15 This contributes to poorer treatment success rates than reported elsewhere. 2 National and global strategies need to restrategise the provision of anti-tuberculosis treatment to ensure that treatment continues across borders.
An analysis of unfavourable treatment outcomes is helpful for public health measures as it is a composite of disease and system outcomes such as treatment default and transfer out rates. Predictors of all-cause mortality are useful in the clinical management of TB. The identification of factors associated with death will allow health care practitioners to appropriately risk-stratify patients for closer surveillance and management. Predictors of unfavourable treatment outcomes are similar to those for mortality except for nationality, absence of BCG scar, smoking status, previous treatment for TB, MDR-TB status and place of residence. Older age, male sex, lower education level, coexisting HIV infection, MDR-TB, EPTB and hospitalisation have also been found to be predictors of treatment outcomes in other studies and systematic reviews. [9] [10] [11] [12] [13] Reasons for the higher mortality among locals than foreign citizens are likely to be due to older age and a higher incidence of concomitant diseases among local citizens.
Smoking was found to be associated with unfavourable treatment outcomes but not death. A study showed that smokers, especially male smokers, were less adherent to anti-tuberculosis treatment, and were therefore at higher risk for poor treatment outcomes. 16 Health care practitioners treating TB patients should therefore actively advocate smoking cessation. This is in tandem with the recommendation by the International Union Against Tuberculosis and Lung Disease (Paris, France) for the inclusion of brief smoking cessation advice in standard TB management. 17 A systematic review found that smoking increased the risk of TB death. 18 In this study, the outcome was all-cause mortality and not TB-related death. It is possible that association with other factors had confounded the results.
The WHO recommends DOT as one of a range of measures of the DOTS strategy to promote adherence to anti-tuberculosis treatment. 19 We have shown that patients who did not receive DOT were nine times more likely to have unfavourable treatment outcomes and death than those who had received DOT. This concurred with findings from programmatic studies that reported an association between the effectiveness of DOT and treatment success.
Other differences between predictors for unfavourable treatment outcomes and those for all-cause mortality were absence of BCG scar, previous treatment for TB, MDR-TB status and place of residence. It is likely that association with other factors resulted in differences found with multivariate analyses. For MDR-TB, the number of cases was too small to draw any conclusions.
It is surprising to note that indigenous people had better treatment outcomes and that DM was not a predictor for unfavourable treatment outcomes or death. Previous medical literature has shown that both of these factors are related to poorer outcomes. 20 The reasons for better treatment outcomes among the indigenous population are likely to be multifactorial. Lower rates of comorbidities, such as DM and HIV infection, and greater DOT coverage in this population are possible reasons for better treatment outcomes. Further study is required to determine the causes for this association. Treatment adherence may be better in those with DM, as these patients are followed up for chronic diabetes management. Surveillance has been increased in DM patients under the National Diabetes Programme, and patients with TB may be detected earlier in this group due to active case detection. Complete data were available for only 70% (n ¼ 15 249) of the cohort. The completeness of the TB registry is critically important to understand local epidemiology and improve TB control. Efforts are needed to ensure that database entry is adhered to by all reporting agencies to ensure proper surveillance and audit. Strategies have been taken to improve data collection and entry into the system.
Strengths and limitations
The database used for the study was huge, with more than 20 000 patients. A limitation was in the amount of missing information. Around one third of the incomplete records had been entered from a local state authority, where TB registry data were collected using the old format and many variables were missing. When multiple imputation was performed using the observed data of other subjects to estimate the distribution of the missing data in the source population, 21 the results of the regression were similar for the group with complete data and those with multiple imputation, except for BCG vaccination (Appendices 1 and 2*). With multiple imputation, BCG vaccination was found to be a protective factor for mortality. Another limitation was that allcause mortality was used for this study because the actual cause of death could not be determined from the database.
?1
Recommendations TB remains a threat to health care, with one in five patients having an unfavourable outcome. Despite the high rates of cure and treatment completion, the rates of unfavourable outcome remain high. Better adherence, using DOT, is needed to improve treatment outcomes. The proper organisation of health care and cooperation between countries may help to reduce poor outcomes such as treatment default and transferred out. Further studies should be conducted to explore the reasons for better treatment outcomes in the indigenous population.
CONCLUSION
The study found that 21.5% of TB patients registered in 2012 had unfavourable treatment outcomes, with half ending in deaths and half transferred out or defaulting from treatment. Intervention strategies should target those at increased risk of unfavourable outcomes. The indigenous population in East Malaysia were found to have lower rates of unfavourable treatment outcomes, including death. This requires further study. 
R E S U M E N O B J E T I V O S:
Determinar la prevalencia de diferentes desenlaces clínicos y sus factores pronósticos en todos los pacientes registrados en el Sistema nacional de vigilancia de la tuberculosis (TB) de Malasia en el 2012.
M É T O D O S:
Se analizaron las características sociodemográ ficas y clínicas de los pacientes. Entre los desenlaces clínicos desfavorables se contaron el fracaso terapéutico, las transferencias a otros centros y la pérdida durante el seguimiento, los pacientes sin investigación clínica y la mortalidad por todas las causas. R E S U LTA D O S: Se registraron 21 582 pacientes. La edad promedio fue 42,36 años (6 17,77) y el 14,2% no era malasio. En su mayoría, se trató de casos nuevos (93,6%). Un quinto de los pacientes presentó desenlaces desfavorables (21,5%); de estos pacientes el 46% falleció, el 49% se transfirió a otro centro o abandonó el tratamiento y un 1% presentó fracaso terapéutico. Los factores pronósticos de un desenlace desfavorable fueron la ancianidad, el sexo masculino, la nacionalidad extranjera, un bajo grado de escolaridad, la ausencia de cicatriz de bacille Calmette-Guérin (BCG), el tratamiento en un entorno de atención terciaria, el tabaquismo, el antecedente de tratamiento antituberculoso, la infección por el virus de la inmunodeficiencia humana, un enfoque terapéutico diferente del tratamiento directamente observado, imá genes radiográ ficas de enfermedad avanzada, la TB multidrogorresistente (TB-MDR) y la TB extrapulmonar. Los factores pronósticos de mortalidad por todas las causas fueron aná logos, con la excepción de la residencia en zona rural y la ciudadanía de un país con tasas má s altas de mortalidad. La ausencia de cicatriz del BCG, el antecedente de tratamiento antituberculoso y la TB-MDR no constituyeron factores pronósticos de mortalidad por todas las causas. Las poblaciones autóctonas del este de Malasia presentaron tasas má s bajas de desenlaces clínicos desfavorables. C O N C L U S I Ó N: Un quinto de los pacientes con diagnóstico de TB presenta desenlaces clínicos desfavorables. Las estrategias de intervención se deben dirigir a las personas con mayor riesgo de sufrir desenlaces desfavorables y muerte por todas las causas.
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